Table 2. Sequencing Statistics.
Cancer Type | Tissue | ENA Accession Number | Input DNA (ng) | Reads (Millions) | Mapped Reads (%) | Paired Reads (%) | On Target Mapped Reads (%) | PCR Duplicates | Mean Sequencing Depth |
---|---|---|---|---|---|---|---|---|---|
Sarcoma | Buffy Coat | ERS700862 | 2000 | 392 | 361 (92.3) | 342 (87.4) | 210 (58) | 29% | 226 |
Sarcoma | Primary Tumor | ERS700863 | 500 | 116 | 114 (98.3) | 113 (96.9) | 93 (81.6) | 31% | 118 |
Sarcoma | cfDNA 1 | ERS700864 | 750 | 250 | 243 (97.1) | 204 (81.6) | 143 (58.9) | 34% | 160 |
Sarcoma | cfDNA 2 | ERS700864 | 110 | 155 | 154.8 (99.7) | 147 (94.4) | 124 (80.4) | 12% | 162 |
Sarcoma | cfDNA 3 | ERS700864 | 110 | 186 | 185 (99.7) | 175 (94.5) | 155 (84.0) | 16% | 203 |
Sarcoma | Pooled cfDNA 1–3 | ERS700864 | 970 | 591 | 583 (98.62) | 526 (89.0) | 423 (72.6) | n/a | 524 |
Breast Cancer | Buffy Coat | ERS700858 | 412 | 182 | 181 (99.6) | 180 (98.8) | 154 (84.8) | 20% | 201 |
Breast Cancer | Primary Tumor | ERS700859 | 301 | 112 | 110.8 (99.2) | 99.1 (88.8) | 92 (82.8) | 52% | 118 |
Breast Cancer | Metastasis | ERS700860 | 341 | 173 | 171.8 (99.5) | 170 (98.6) | 140 (81.6) | 22% | 183 |
Breast Cancer | cfDNA | ERS700861 | 155 | 286 | 284.8 (99.5) | 253 (88.5) | 239 (83.8) | 37% | 309 |